Bingxia Ming

636 total citations
24 papers, 376 citations indexed

About

Bingxia Ming is a scholar working on Immunology, Rheumatology and Physiology. According to data from OpenAlex, Bingxia Ming has authored 24 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 7 papers in Rheumatology and 7 papers in Physiology. Recurrent topics in Bingxia Ming's work include Immune Cell Function and Interaction (7 papers), Salivary Gland Disorders and Functions (7 papers) and Advanced Glycation End Products research (5 papers). Bingxia Ming is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Salivary Gland Disorders and Functions (7 papers) and Advanced Glycation End Products research (5 papers). Bingxia Ming collaborates with scholars based in China, United States and Japan. Bingxia Ming's co-authors include Lingli Dong, Fang Zheng, Jixin Zhong, Feili Gong, Zheng Tan, Ming Gao, Huijuan Zou, Xuefen Wu, Yong Xu and Lingli Dong and has published in prestigious journals such as The Journal of Immunology, Neuroscience and Frontiers in Immunology.

In The Last Decade

Bingxia Ming

23 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingxia Ming China 12 191 71 70 70 67 24 376
Lingli Dong China 12 146 0.8× 66 0.9× 109 1.6× 95 1.4× 48 0.7× 20 357
Huaxi Xu China 10 350 1.8× 92 1.3× 141 2.0× 81 1.2× 27 0.4× 12 613
Niamh Bermingham Ireland 10 107 0.6× 77 1.1× 88 1.3× 30 0.4× 35 0.5× 25 425
Huoying Chen China 10 164 0.9× 12 0.2× 111 1.6× 31 0.4× 44 0.7× 21 358
Yeqi Nian China 12 145 0.8× 19 0.3× 102 1.5× 89 1.3× 83 1.2× 31 415
Phani K. Patibandla United States 8 56 0.3× 32 0.5× 97 1.4× 41 0.6× 42 0.6× 14 349
Isabella Fiorentino Italy 7 178 0.9× 27 0.4× 133 1.9× 79 1.1× 54 0.8× 7 396
Shuo Niu United States 8 188 1.0× 14 0.2× 69 1.0× 70 1.0× 59 0.9× 31 358
Wataru Fujii Japan 11 213 1.1× 46 0.6× 128 1.8× 35 0.5× 9 0.1× 24 424
Takashi Akasaki Japan 9 139 0.7× 36 0.5× 139 2.0× 115 1.6× 33 0.5× 13 453

Countries citing papers authored by Bingxia Ming

Since Specialization
Citations

This map shows the geographic impact of Bingxia Ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingxia Ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingxia Ming more than expected).

Fields of papers citing papers by Bingxia Ming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingxia Ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingxia Ming. The network helps show where Bingxia Ming may publish in the future.

Co-authorship network of co-authors of Bingxia Ming

This figure shows the co-authorship network connecting the top 25 collaborators of Bingxia Ming. A scholar is included among the top collaborators of Bingxia Ming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingxia Ming. Bingxia Ming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ling, et al.. (2025). The clinical and immunological features of CMV infection in rheumatic patients: a nested case-control study. Clinical Rheumatology. 44(7). 3033–3047.
2.
Ming, Bingxia, Ling Li, Shaozhe Cai, et al.. (2025). How to focus on autoantigen-specific lymphocytes: a review on diagnosis and treatment of Sjogren's syndrome. Journal of Leukocyte Biology. 117(2). 1 indexed citations
3.
Ming, Bingxia, et al.. (2022). Clinical characteristics of SLE patients infected with Epstein-Barr virus and potential associated risk factors. Clinical Rheumatology. 42(1). 101–109. 6 indexed citations
4.
Ming, Bingxia, et al.. (2022). The Role of HMGB1 in Rheumatic Diseases. Frontiers in Immunology. 13. 815257–815257. 23 indexed citations
5.
Ming, Bingxia, Yaowu Zhu, Jixin Zhong, & Lingli Dong. (2022). Immunopathogenesis of Sjogren's syndrome: Current state of DAMPs. Seminars in Arthritis and Rheumatism. 56. 152062–152062. 10 indexed citations
6.
Wu, Xuefen, Bingxia Ming, Rongfen Gao, et al.. (2022). IL-33/ST2 axis contributes to the dermal fibrosis of systemic sclerosis via promoting fibroblasts activation. Journal of Dermatological Science. 107(2). 95–104. 5 indexed citations
7.
Gao, Rongfen, Jungen Tang, Bingxia Ming, et al.. (2022). The aberrant levels of decorin induce damages of human salivary gland epithelial cells and polarization of macrophages. Modern Rheumatology. 33(3). 557–565. 7 indexed citations
8.
Hu, Peng, Bingxia Ming, Xuefen Wu, et al.. (2021). Intratracheal Poly(I:C) Exposure Accelerates the Immunological Disorder of Salivary Glands in Sjogren's-Like NOD/ShiLtJ Mice. Frontiers in Medicine. 8. 645816–645816. 4 indexed citations
9.
Ming, Bingxia, Jixin Zhong, & Lingli Dong. (2021). Role of eosinophilia in IgG4-related disease. Clinical and Experimental Rheumatology. 10 indexed citations
10.
Zou, Huijuan, Bingxia Ming, Jun Li, et al.. (2021). Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling. Frontiers in Immunology. 12. 641973–641973. 16 indexed citations
11.
Zhu, Yingzi, et al.. (2019). Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis. Lupus. 28(4). 445–454. 27 indexed citations
12.
Geng, Zhe, et al.. (2019). α-Difluoromethylornithine suppresses inflammatory arthritis by impairing myeloid-derived suppressor cells. International Immunopharmacology. 71. 251–258. 13 indexed citations
13.
Ming, Bingxia, Xuefen Wu, Shaozhe Cai, et al.. (2019). Sphingomyelin synthase 1 enhances BCR signaling to promote lupus-like autoimmune response. EBioMedicine. 45. 578–587. 11 indexed citations
14.
Cai, Shaozhe, Bingxia Ming, Cong Ye, et al.. (2019). Similar Transition Processes in Synovial Fibroblasts from Rheumatoid Arthritis and Osteoarthritis: A Single-Cell Study. Journal of Immunology Research. 2019. 1–11. 22 indexed citations
15.
Luo, Jing, Bingxia Ming, Cai Zhang, et al.. (2018). IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren’s Syndrome Patients. Frontiers in Immunology. 9. 1755–1755. 40 indexed citations
16.
Ming, Bingxia, Ming Gao, Huijuan Zou, et al.. (2016). HMGB1 blockade differentially impacts pulmonary inflammation and defense responses in poly(I:C)/LPS-exposed heart transplant mice. Molecular Immunology. 76. 80–89. 2 indexed citations
17.
Sun, Yun, Yichen Xiao, Bingxia Ming, et al.. (2015). Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice. Neuroscience. 308. 157–168. 47 indexed citations
18.
Sun, Yan, Huoying Chen, Jiapei Dai, et al.. (2015). HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 280. 29–35. 34 indexed citations
19.
Yan, Yutao, Yu Ding, Bingxia Ming, et al.. (2014). Increase in Hypotonic Stress-Induced Endocytic Activity in Macrophages via ClC-3. Molecules and Cells. 37(5). 418–425. 13 indexed citations
20.
Zou, Huijuan, Yan Yang, Ming Gao, et al.. (2014). HMGB1 Is Involved in Chronic Rejection of Cardiac Allograft via Promoting Inflammatory-Like mDCs. American Journal of Transplantation. 14(8). 1765–1777. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026